Leah J Blank1, Emily K Acton2, Allison W Willis2. 1. From the Department of Neurology, Division of Health Outcomes and Knowledge Translational Research (L.J.B.), and Department of Population Health Science and Policy (L.J.B.), Icahn School of Medicine at Mount Sinai, New York, NY; Center for Clinical Epidemiology and Biostatistics (E.K.A., A.W.W.), Department of Neurology Translational Center of Excellence for Neuroepidemiology and Neurological Outcomes Research (E.K.A., A.W.W.), Department of Neurology (A.W.W.), Department of Biostatistics, Epidemiology and Informatics (A.W.W.), and Leonard Davis Institute of Health Economics (A.W.W.), University of Pennsylvania Perelman School of Medicine, Philadelphia. Leah.Blank@mssm.edu. 2. From the Department of Neurology, Division of Health Outcomes and Knowledge Translational Research (L.J.B.), and Department of Population Health Science and Policy (L.J.B.), Icahn School of Medicine at Mount Sinai, New York, NY; Center for Clinical Epidemiology and Biostatistics (E.K.A., A.W.W.), Department of Neurology Translational Center of Excellence for Neuroepidemiology and Neurological Outcomes Research (E.K.A., A.W.W.), Department of Neurology (A.W.W.), Department of Biostatistics, Epidemiology and Informatics (A.W.W.), and Leonard Davis Institute of Health Economics (A.W.W.), University of Pennsylvania Perelman School of Medicine, Philadelphia.
Abstract
OBJECTIVE: To determine the incidence of epilepsy and subsequent 5-year mortality among older adults, as well as characteristics associated with mortality. METHODS: This was a retrospective cohort study of Medicare beneficiaries age 65 or above with at least 2 years enrollment before January 2009. Incident epilepsy cases were identified in 2009 using ICD-9-CM code-based algorithms; death was assessed through 2014. Cox regression models examined the association between 5-year mortality and incident epilepsy, and whether mortality differed by sociodemographic characteristics or comorbid disorders. RESULTS: Among the 99,990 of 33,615,037 beneficiaries who developed epilepsy, most were White (79.7%), female (57.3%), urban (80.5%), and without Medicaid (71.3%). The 5-year mortality rate for incident epilepsy was 62.8% (62,838 deaths). In multivariable models, lower mortality was associated with female sex (adjusted hazards ratio [AHR] 0.85, 95% confidence interval [CI] 0.84-0.87), Asian race (AHR 0.82, 95% CI 0.76-0.88), and Hispanic ethnicity (AHR 0.81, 95% CI 0.76-0.84). Hazard of death increased with comorbid disease burden (per 1-point increase: AHR 1.27, 95% CI 1.26-1.27) and Medicaid coinsurance (AHR 1.17, 95% CI 1.14-1.19). Incident epilepsy was particularly associated with higher mortality when diagnosed after another neurologic condition: Parkinson disease (AHR 1.29, 95% CI 1.21-1.38), multiple sclerosis (AHR 2.13, 95% CI 1.79-2.59), dementia (AHR 1.33, 95% CI 1.31-1.36), traumatic brain injury (AHR 1.55, 95% CI 1.45-1.66), and stroke/TIA (AHR 1.20, 95% CI 1.18-1.21). CONCLUSIONS: Newly diagnosed epilepsy is associated with high 5-year mortality among Medicare beneficiaries. Future studies that parse the interplay of effects from underlying disease, race, sex, and poverty on mortality will be critical in the design of learning health care systems to reduce premature deaths.
OBJECTIVE: To determine the incidence of epilepsy and subsequent 5-year mortality among older adults, as well as characteristics associated with mortality. METHODS: This was a retrospective cohort study of Medicare beneficiaries age 65 or above with at least 2 years enrollment before January 2009. Incident epilepsy cases were identified in 2009 using ICD-9-CM code-based algorithms; death was assessed through 2014. Cox regression models examined the association between 5-year mortality and incident epilepsy, and whether mortality differed by sociodemographic characteristics or comorbid disorders. RESULTS: Among the 99,990 of 33,615,037 beneficiaries who developed epilepsy, most were White (79.7%), female (57.3%), urban (80.5%), and without Medicaid (71.3%). The 5-year mortality rate for incident epilepsy was 62.8% (62,838 deaths). In multivariable models, lower mortality was associated with female sex (adjusted hazards ratio [AHR] 0.85, 95% confidence interval [CI] 0.84-0.87), Asian race (AHR 0.82, 95% CI 0.76-0.88), and Hispanic ethnicity (AHR 0.81, 95% CI 0.76-0.84). Hazard of death increased with comorbid disease burden (per 1-point increase: AHR 1.27, 95% CI 1.26-1.27) and Medicaid coinsurance (AHR 1.17, 95% CI 1.14-1.19). Incident epilepsy was particularly associated with higher mortality when diagnosed after another neurologic condition: Parkinson disease (AHR 1.29, 95% CI 1.21-1.38), multiple sclerosis (AHR 2.13, 95% CI 1.79-2.59), dementia (AHR 1.33, 95% CI 1.31-1.36), traumatic brain injury (AHR 1.55, 95% CI 1.45-1.66), and stroke/TIA (AHR 1.20, 95% CI 1.18-1.21). CONCLUSIONS: Newly diagnosed epilepsy is associated with high 5-year mortality among Medicare beneficiaries. Future studies that parse the interplay of effects from underlying disease, race, sex, and poverty on mortality will be critical in the design of learning health care systems to reduce premature deaths.
Authors: Vicenta Salanova; Thomas Witt; Robert Worth; Thomas R Henry; Robert E Gross; Jules M Nazzaro; Douglas Labar; Michael R Sperling; Ashwini Sharan; Evan Sandok; Adrian Handforth; John M Stern; Steve Chung; Jaimie M Henderson; Jacqueline French; Gordon Baltuch; William E Rosenfeld; Paul Garcia; Nicholas M Barbaro; Nathan B Fountain; W Jeffrey Elias; Robert R Goodman; John R Pollard; Alexander I Tröster; Christopher P Irwin; Kristin Lambrecht; Nina Graves; Robert Fisher Journal: Neurology Date: 2015-02-06 Impact factor: 9.910
Authors: Dulaney A Wilson; Angela M Malek; Janelle L Wagner; Braxton B Wannamaker; Anbesaw W Selassie Journal: Epilepsy Res Date: 2016-02-20 Impact factor: 3.045
Authors: E Faught; J Richman; R Martin; E Funkhouser; R Foushee; P Kratt; Y Kim; K Clements; N Cohen; D Adoboe; R Knowlton; M Pisu Journal: Neurology Date: 2012-01-18 Impact factor: 9.910
Authors: C A Granbichler; W Oberaigner; G Kuchukhidze; J-P Ndayisaba; A Ndayisaba; A Taylor; G Bauer; G Luef; E Trinka Journal: Eur J Neurol Date: 2017-02-27 Impact factor: 6.089
Authors: Georita M Frierson; Erica N Howard; Laura E DeFina; Tiffany M Powell-Wiley; Benjamin L Willis Journal: Ethn Dis Date: 2013 Impact factor: 1.847
Authors: Hyunmi Choi; Alison Pack; Mitchell S V Elkind; W T Longstreth; Thanh G N Ton; Frankline Onchiri Journal: Neurology Date: 2017-01-27 Impact factor: 9.910
Authors: Gabriella Wojewodka; Martin C Gulliford; Mark Ashworth; Mark P Richardson; Leone Ridsdale Journal: BMJ Open Date: 2021-10-25 Impact factor: 2.692